供使用AI工具的研究人员参考
AI 智能体
Atlas 专为机器可读而设计。每条记录均以结构化 JSON 格式提供,每个页面均包含 schema.org 标记,且记录之间的关联关系清晰明确。这些提示词可将 AI 助手直接指向这些数据,而非让它自行发挥。
使用须知
对这些数据进行总结的助手,归根结底仍只是一个总结工具:请将其给出的内容与所链接的页面及其中引用的原始资料核对核实。任何情况下,都不要将这些信息用于自己的医疗决策。
可直接复制使用的提示词
每个提示词均已接入本站实时 API,可粘贴到 Claude、ChatGPT、Gemini 或任何支持访问 URL 的 AI 助手中使用。
已获批疗法查询
Using only https://crispr2.2.25.209.181.nip.io/api/v1/entities?kind=treatment as your source, list every gene-editing treatment whose status is "Approved". For each, give the disease it treats, the technology it uses, the company, and the URL of its Atlas page. If a field is missing in the data, say "not recorded" rather than filling it in from memory. Finish by stating plainly that approval in one country does not mean availability everywhere.
疾病全景简报
Fetch https://crispr2.2.25.209.181.nip.io/api/v1/entity/disease/DISEASE-SLUG (replace DISEASE-SLUG, e.g. sickle-cell-disease). Write a 300-word briefing for an intelligent non-specialist covering: what the disease is, which genes are involved, what gene-editing approaches are being tried, which companies and trials appear in the related records, and — most importantly — the evidence level attached to each claim. Do not present anything preclinical as if it were an available treatment.
试验阶段扫描
Fetch https://crispr2.2.25.209.181.nip.io/api/v1/trials and group the results by phase. For each phase, list the trials with their disease, sponsor and NCT identifier. Flag any trial whose status is Paused, Terminated or Discontinued and say so prominently. Note that Atlas records carry a last-updated date and that ClinicalTrials.gov is authoritative for current status.
技术对比
Fetch https://crispr2.2.25.209.181.nip.io/api/v1/entities?kind=technology. Build a comparison table of CRISPR-Cas9, base editing and prime editing covering: what it edits, whether it cuts both DNA strands, precision, cargo size, delivery difficulty and clinical maturity — using only the fields in the data. Then write two paragraphs explaining, to a 15-year-old, why not cutting both strands matters.
企业研发管线摘要
Fetch https://crispr2.2.25.209.181.nip.io/api/v1/entity/company/COMPANY-SLUG (e.g. crispr-therapeutics). Summarise the company's disclosed pipeline stage by stage, name its partners and the diseases it targets, and list its related trials. State the record's last-updated date at the top. Add: this is educational information, not investment advice, and pipelines change frequently.
用孩子能懂的方式解释
Fetch https://crispr2.2.25.209.181.nip.io/api/v1/entity/technology/TECHNOLOGY-SLUG (e.g. base-editing) and use the "simple" field as your starting point. Explain the technology to a curious 11-year-old in under 200 words, using one analogy — then add one short paragraph explaining exactly where that analogy stops being accurate. Keep it honest rather than exciting.
API
免费、只读,无需密钥。请缓存数据并注明来源链接。
/api/v1/entities?kind=…
涵盖各类记录:技术、疾病、治疗、试验、公司、科学家、基因、论文、机构、伦理、农业、学习资源、术语表。
/api/v1/entity/{kind}/{slug}
完整呈现一条记录,包括知识图谱中所有相关记录。
/api/v1/trials
可按阶段和状态筛选的试验数据库。
/api/v1/news
标题、出版方及链接。文章正文归各出版方所有。
为什么结构很重要
实体条目,非文章
一种疾病、一个基因、一项试验和一家公司,各自都是独立记录,拥有固定的网址——这样助手可以沿着关系链查找,而不是凭空猜测。
证据是一个字段
每条记录都标注了明确的证据级别,让模型无需"读字里行间",就能区分已获批药物与小鼠实验结果。
置顶回答
每个页面都以一句话直接给出答案,再展开详细内容——这正是读者和检索系统真正需要的。